Chatbot to help quitting smoking in Black adults in Minnesota

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized feasibility study compares outcomes between participants who receive a newly developed smoking-cessation chatbot and those who do not. Adult Black or African American smokers in Minnesota, who are ready to quit within 30 days and own a smartphone, are enrolled to assess acceptability and early signals of effectiveness. Participants will use the app, receive study-related text reminders, and data may be uploaded from the app to track engagement and progress. The trial aims to gather initial information on whether the chatbot can support quit attempts in this population. Lead sponsor is the University of Minnesota, with collaboration from NIMHD, at the Minneapolis site.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Identify as Black or African American
* Be at least 21 years of age
* Meet a minimum smoking amount
* Be willing to make a quit attempt in the next 30 days
* Have a smartphone capable of downloading and running the study app
* Be able to upload data from the app
* Agree to receive text message reminders about study activities
* Be a native English speaker
* Reside in Minnesota.

Exclusion Criteria:

* Medicinal nicotine use would require careful monitoring by a healthcare professional
* Medical condition or medication used likely to significantly interfere with study outcomes or to be significantly affected by changes in smoking behavior
* Are pregnant or breastfeeding

Where it's running

• University of Minnesota
  Minneapolis, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Michael Kotlyar — University of Minnesota
• Study coordinator: Sheena Study Coordinator
• Email: gahmx008@umn.edu
• Phone: 612-626-5981

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Communal coping in couples where both partners smoke during a quit attempt

  This project tests whether couples who tackle quitting as a team (communal coping) fare better when one partner in a smoking couple tries to quit.

  Recruiting University of Colorado, Denver · Denver, Colorado · NCT07553962

• Varenicline plus enhanced TMS to help adults quit smoking and vaping

  This study tests whether adding active enhanced accelerated transcranial magnetic stimulation (aTMS) to varenicline helps adults 18–65 quit nicotine use more effectively than varenicline with sham stimulation.

  Recruiting Phase 4 Massachusetts General Hospital · Boston, Massachusetts · NCT07145866

• ACT Lung Health Program to help Chinese and Korean American smokers quit

  This trial tests a counseling and educational program to help Chinese and Korean American smokers at high risk for lung cancer quit smoking.

  Recruiting at 2 sites Dana-Farber Cancer Institute · Boston, Massachusetts and 1 other locations · NCT06945120

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Using an air quality monitor to encourage smoke-free homes for cancer patients

  This study is testing if using an air quality monitor can help cancer patients who smoke create smoke-free homes and quit smoking.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 7 other locations · NCT06693700

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.